Stability-indicating simultaneous HPTLC method for olanzapine and fluoxetine in combined tablet dosage form

Indian Journal of Pharmaceutical Sciences

Volumn 70, Issue 2, 2008, Pages 251-255

  Shah, C ^a   Suhagia, B ^b   Shah, N ^a   Patel, D ^a   Patel, N ^a  

^a Shri B M Shah College of Pharmacy Modasa   (India)

^b L M COLLEGE OF PHARMACY   (India)

Author keywords

Fluoxetine; Forced degradation; HPTLC; Olanzapine; Simultaneous estimation; Stability indicating method

Indexed keywords

FLUOXETINE; FLUOXETINE PLUS OLANZAPINE; OLANEX F; OLANZAPINE;

ACCURACY; ARTICLE; DRUG DEGRADATION; DRUG RESEARCH; DRUG STABILITY; HIGH PERFORMANCE THIN LAYER CHROMATOGRAPHY; PHOTODEGRADATION; TABLET FORMULATION; TEMPERATURE STRESS; ULTRAVIOLET RADIATION;

EID: 46349085150     PISSN: 0250474X     EISSN: 19983743     Source Type: Journal    
DOI: 10.4103/0250-474X.41469     Document Type: Article

References (13)

1. Manickam A, Donna A, William CW, Stephen RM. Determination by high performance liquid chromatography with electrochemical detection. Ther Drug Monit 1997;19:307-13.
2. Labat L, Deveaux M, Dallet P, Dubost JP. Separation of new antidepressants and their metabolites by micellar electrokinetic capillary chromatography. J Chromatogr B Biomed Sci Appl 2002;773:17-23.
3. Zhang W, Kenneth WP, David TW, Potts BD, Bao J, Tollefson GD, et al. Synergistic effects of olanzapine and other antipsychotic agents in combination with fluoxetine on norepinephrine and dopamine release in rat prefrontal cortex. Neuropshycopharmacology 2000;23:250-62.
4. Raggi MA, Casamenti G, Mandrioli R, Lzzo G, Kenndler E. Quantitation of olanzapine in tablets by HPLC, CZE, derivative spectrometry and linear voltammetry. J Pharm Biomed Anal 2000;23:973-81.
5. Bugamelli F, Volterra V, Raggi MA, Casamenti G, Mandrioli R. Determination of fluoxetine and norfluoxetine in human plasma by high-pressure liquid chromatography with fluorescence detection. J Pharm Biomed Anal 1998;18:193-9.
6. Bao J, Potts BD. Quantitative determination of olanzapine in rat brain tissue by high-performance liquid chromatography with electrochemical detection. J Chromatogr B Biomed Sci Appl 2001;752:61-7.
7. Dasoondi B, Shah P, Gandhi C, Bhat KM. Development of HPLC assays method for the estimation of olanzapine in human plasma and its application to pharmacokinetics. Indian J Pharm Sci 2003;40:350-4.
8. Khan GJ, Trivedi C, Soni K, Khan IJ, Saraf MN. Bioanalytical method development, validation and comparative bioavailability studies of fluoxetine extended release tablets in healthy human volunteers. Indian Drugs 2005;42:580-4.
9. Reynolds DW, Facchine KL, Mullaney FJ, Alsante KM, Hatajik TD, Michel MG. Available guidance and best practices for conducting forced degradation studies. Pharm Technol 2002;15:48-56.
10. ICH. Q1AR stability testing of new drug substances and products. International Conference on Harmonization, Geneva: 1993 October.
11. Sethi PD. High performance thin layer chromatography: Quantitative analysis of pharmaceutical formulation. 2nd ed. New Delhi: CBS Publishers; 1996. p. 3-62.
12. Fried B, Sharma J. Thin layer chromatography: Techniques and application. 3rd ed. New York: Marcel Dekker; 1994. p. 11-22.
13. ICH. Q2B Validation of analytical procedure: Methodology. International Conference on Harmonization, Geneva; 1996 March.